Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Brandon Henry and Giuseppe Lippi.
Brandon Henry
Connection Strength
44.065
Giuseppe Lippi
  1. Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis. Clin Chem Lab Med. 2022 01 26; 60(1):e1-e3.
    View in: PubMed
    Score: 0.965
  2. Clinical Predictors of SARS-CoV-2 Testing Pressure on Clinical Laboratories: A Multinational Study Analyzing Google Trends and Over 100 Million Diagnostic Tests. Lab Med. 2021 Jul 01; 52(4):311-314.
    View in: PubMed
    Score: 0.954
  3. Pooled analysis of mid-regional pro-adrenomedullin values in COVID-19 patients with critical illness. Intern Emerg Med. 2021 09; 16(6):1723-1725.
    View in: PubMed
    Score: 0.944
  4. Are sniffer dogs a reliable approach for diagnosing SARS-CoV-2 infection? Diagnosis (Berl). 2021 11 25; 8(4):446-449.
    View in: PubMed
    Score: 0.941
  5. Alterations in the lipid profile associate with a dysregulated inflammatory, prothrombotic, anti-fibrinolytic state and development of severe acute kidney injury in coronavirus disease 2019 (COVID-19): A study from Cincinnati, USA. Diabetes Metab Syndr. 2021 May-Jun; 15(3):863-868.
    View in: PubMed
    Score: 0.940
  6. How will emerging SARS-CoV-2 variants impact herd immunity? Ann Transl Med. 2021 Apr; 9(7):585.
    View in: PubMed
    Score: 0.938
  7. Response to: Eosinophil count in coronavirus disease 2019: more doubts than answers. QJM. 2021 02 18; 114(1):70-71.
    View in: PubMed
    Score: 0.930
  8. Pooled analysis of monocyte distribution width in subjects with SARS-CoV-2 infection. Int J Lab Hematol. 2021 08; 43(4):O161-O163.
    View in: PubMed
    Score: 0.928
  9. Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis. Eur J Gastroenterol Hepatol. 2021 01; 33(1):114-115.
    View in: PubMed
    Score: 0.922
  10. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19). Diagnosis (Berl). 2020 Nov 18; 7(4):409-411.
    View in: PubMed
    Score: 0.914
  11. Response to: Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity? J Diabetes. 2021 02; 13(2):179-180.
    View in: PubMed
    Score: 0.914
  12. Coronavirus Disease 2019-Associated Coagulopathy. Mayo Clin Proc. 2021 01; 96(1):203-217.
    View in: PubMed
    Score: 0.911
  13. Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis. Acta Biomed. 2020 09 07; 91(3):e2020008.
    View in: PubMed
    Score: 0.902
  14. Red Blood Cell Distribution Width (RDW) Predicts COVID-19 Severity: A Prospective, Observational Study from the Cincinnati SARS-CoV-2 Emergency Department Cohort. Diagnostics (Basel). 2020 Aug 21; 10(9).
    View in: PubMed
    Score: 0.899
  15. Repeated Testing in SARS-CoV-2 Infection. Mayo Clin Proc. 2020 10; 95(10):2283-2284.
    View in: PubMed
    Score: 0.897
  16. Eosinophil count in severe coronavirus disease 2019. QJM. 2020 07 01; 113(7):511-512.
    View in: PubMed
    Score: 0.890
  17. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020 06 25; 58(7):1021-1028.
    View in: PubMed
    Score: 0.889
  18. Clinical and demographic characteristics of patients dying from COVID-19 in Italy vs China. J Med Virol. 2020 10; 92(10):1759-1760.
    View in: PubMed
    Score: 0.885
  19. COVID-19: unravelling the clinical progression of nature's virtually perfect biological weapon. Ann Transl Med. 2020 Jun; 8(11):693.
    View in: PubMed
    Score: 0.885
  20. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review. Clin Biochem. 2020 Jul; 81:1-8.
    View in: PubMed
    Score: 0.884
  21. Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. Am J Emerg Med. 2020 09; 38(9):1722-1726.
    View in: PubMed
    Score: 0.884
  22. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem. 2020 05; 57(3):262-265.
    View in: PubMed
    Score: 0.880
  23. Active smoking and COVID-19: a double-edged sword. Eur J Intern Med. 2020 07; 77:123-124.
    View in: PubMed
    Score: 0.880
  24. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta. 2020 Aug; 507:167-173.
    View in: PubMed
    Score: 0.879
  25. Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis. Intern Emerg Med. 2020 08; 15(5):857-859.
    View in: PubMed
    Score: 0.877
  26. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports. J Crit Care. 2020 08; 58:27-28.
    View in: PubMed
    Score: 0.875
  27. Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm. Ann Transl Med. 2020 Apr; 8(7):497.
    View in: PubMed
    Score: 0.875
  28. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020 04 30; 130(4):304-309.
    View in: PubMed
    Score: 0.875
  29. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020 06; 52(6):1193-1194.
    View in: PubMed
    Score: 0.874
  30. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med. 2020 06; 167:105941.
    View in: PubMed
    Score: 0.873
  31. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). Eur J Intern Med. 2020 05; 75:107-108.
    View in: PubMed
    Score: 0.872
  32. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020 Jul; 506:145-148.
    View in: PubMed
    Score: 0.872
  33. Myalgia may not be associated with severity of coronavirus disease 2019 (COVID-19). World J Emerg Med. 2020; 11(3):193-194.
    View in: PubMed
    Score: 0.860
  34. False-Positive Rates in Pediatric SARS-CoV-2 Serology Testing. Am J Clin Pathol. 2022 02 03; 157(2):314-316.
    View in: PubMed
    Score: 0.248
  35. Anti-SARS-CoV-2 IgA Response in Baseline Seronegative and Seropositive Recipients of BNT162b2 mRNA COVID-19 Vaccine. J Occup Environ Med. 2021 11 01; 63(11):e829.
    View in: PubMed
    Score: 0.244
  36. Searching for a clinically validated definition of "asymptomatic" COVID-19 infection. Int J Clin Pract. 2021 Sep; 75(9):e14085.
    View in: PubMed
    Score: 0.241
  37. The strength of association between pre-and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay. Int J Infect Dis. 2021 Oct; 111:65-67.
    View in: PubMed
    Score: 0.241
  38. Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals. Diagnosis (Berl). 2021 08 18; 9(1):146-148.
    View in: PubMed
    Score: 0.241
  39. Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms? J Infect. 2022 01; 84(1):94-118.
    View in: PubMed
    Score: 0.239
  40. Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers. J Infect. 2021 08; 83(2):e4-e5.
    View in: PubMed
    Score: 0.238
  41. Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay. EJIFCC. 2021 Jun; 32(2):216-223.
    View in: PubMed
    Score: 0.238
  42. Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay. Clin Chem Lab Med. 2021 09 27; 59(10):e377-e379.
    View in: PubMed
    Score: 0.238
  43. COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check? Semin Thromb Hemost. 2022 Feb; 48(1):72-92.
    View in: PubMed
    Score: 0.238
  44. Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature. Semin Thromb Hemost. 2022 Feb; 48(1):55-71.
    View in: PubMed
    Score: 0.238
  45. Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients. Clin Chem Lab Med. 2021 10 26; 59(11):e413-e415.
    View in: PubMed
    Score: 0.238
  46. Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection. Ann Intern Med. 2021 06; 174(6):885-886.
    View in: PubMed
    Score: 0.237
  47. Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How? Diagnostics (Basel). 2021 May 25; 11(6).
    View in: PubMed
    Score: 0.237
  48. Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state. J Med Virol. 2021 09; 93(9):5515-5522.
    View in: PubMed
    Score: 0.237
  49. Serum ACE activity and plasma ACE concentration in patients with SARS-CoV-2 infection. Scand J Clin Lab Invest. 2021 07; 81(4):272-275.
    View in: PubMed
    Score: 0.236
  50. The complicated relationships of heparin-induced thrombocytopenia and platelet factor 4 antibodies with COVID-19. Int J Lab Hematol. 2021 Aug; 43(4):547-558.
    View in: PubMed
    Score: 0.236
  51. Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination. Diagnostics (Basel). 2021 May 04; 11(5).
    View in: PubMed
    Score: 0.236
  52. Mean Platelet Volume Predicts Severe COVID-19 Illness. Semin Thromb Hemost. 2021 06; 47(4):456-459.
    View in: PubMed
    Score: 0.235
  53. Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis. Semin Thromb Hemost. 2021 Jun; 47(4):400-418.
    View in: PubMed
    Score: 0.235
  54. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series. Clin Chem Lab Med. 2021 Aug 26; 59(9):1585-1591.
    View in: PubMed
    Score: 0.235
  55. Cytokeratin 18 cell death assays as biomarkers for quantification of apoptosis and necrosis in COVID-19: a prospective, observational study. J Clin Pathol. 2021 Mar 31.
    View in: PubMed
    Score: 0.234
  56. Utility of Google Trends in anticipating COVID-19 outbreaks in Poland. Pol Arch Intern Med. 2021 04 29; 131(4):389-392.
    View in: PubMed
    Score: 0.234
  57. Circulating level of Angiopoietin-2 is associated with acute kidney injury in coronavirus disease 2019 (COVID-19). Angiogenesis. 2021 08; 24(3):403-406.
    View in: PubMed
    Score: 0.234
  58. Is COVID-19 impacting prostate cancer screening? A survey of prostate-specific antigen test requests during a local outbreak. EJIFCC. 2021 Feb; 32(1):69-77.
    View in: PubMed
    Score: 0.233
  59. Evaluation of indoor hospital acclimatization of body temperature before COVID-19 fever screening. J Hosp Infect. 2021 06; 112:127-128.
    View in: PubMed
    Score: 0.233
  60. Comparison of forehead temperature screening with infra-red thermometer and thermal imaging scanner. J Hosp Infect. 2021 05; 111:208-209.
    View in: PubMed
    Score: 0.232
  61. Healthcare indicators associated with COVID-19 death rates in the European Union. Public Health. 2021 Apr; 193:41-42.
    View in: PubMed
    Score: 0.232
  62. Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA. Eur J Hosp Pharm. 2021 Jan 27.
    View in: PubMed
    Score: 0.232
  63. Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study. Semin Thromb Hemost. 2021 06; 47(4):451-455.
    View in: PubMed
    Score: 0.231
  64. Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis. Semin Thromb Hemost. 2021 Jun; 47(4):392-399.
    View in: PubMed
    Score: 0.231
  65. Clinical assessment of the Roche SARS-CoV-2 rapid antigen test. Diagnosis (Berl). 2021 08 26; 8(3):322-326.
    View in: PubMed
    Score: 0.231
  66. Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness. Semin Thromb Hemost. 2021 06; 47(4):460-462.
    View in: PubMed
    Score: 0.230
  67. Putative impact of the COVID-19 pandemic on anxiety, depression, insomnia and stress. Eur J Psychiatry. 2021 Jul-Sep; 35(3):200-201.
    View in: PubMed
    Score: 0.229
  68. ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: Evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy. Int J Lab Hematol. 2021 Jul; 43 Suppl 1:129-136.
    View in: PubMed
    Score: 0.229
  69. Making sense of rapid antigen testing in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics. Diagnosis (Berl). 2020 Nov 26.
    View in: PubMed
    Score: 0.229
  70. The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19). Clin Chem Lab Med. 2021 02 23; 59(3):599-607.
    View in: PubMed
    Score: 0.229
  71. False negative RT-PCR or false positive serological testing in SARS-CoV-2 diagnostics? Navigating between Scylla and Charybdis to prevent misclassification bias in COVID-19 clinical investigations. Diagnosis (Berl). 2020 Nov 18; 7(4):405-407.
    View in: PubMed
    Score: 0.228
  72. Do sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression explain increased severity and mortality of COVID-19 in males? Diagnosis (Berl). 2020 Nov 18; 7(4):385-386.
    View in: PubMed
    Score: 0.228
  73. Potential drawbacks of frequent asymptomatic coronavirus disease 2019 (COVID-19) testing. Infect Control Hosp Epidemiol. 2021 11; 42(11):1405-1406.
    View in: PubMed
    Score: 0.228
  74. Anemia and COVID-19: A prospective perspective. J Med Virol. 2021 02; 93(2):708-711.
    View in: PubMed
    Score: 0.226
  75. Coronavirus disease 2019 is associated with low circulating plasma levels of angiotensin 1 and angiotensin 1,7. J Med Virol. 2021 02; 93(2):678-680.
    View in: PubMed
    Score: 0.226
  76. In reply- Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19. Mayo Clin Proc. 2020 11; 95(11):2561-2563.
    View in: PubMed
    Score: 0.226
  77. Updates on laboratory investigations in coronavirus disease 2019 (COVID-19). Acta Biomed. 2020 09 07; 91(3):e2020030.
    View in: PubMed
    Score: 0.225
  78. SARS-CoV-2 recurrent RNA positivity after recovering from coronavirus disease 2019 (COVID-19): a meta-analysis. Acta Biomed. 2020 09 07; 91(3):e2020014.
    View in: PubMed
    Score: 0.225
  79. Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19). Semin Thromb Hemost. 2020 10; 46(7):859-862.
    View in: PubMed
    Score: 0.225
  80. Red Blood Cell Distribution Is a Significant Predictor of Severe Illness in Coronavirus Disease 2019. Acta Haematol. 2021; 144(4):360-364.
    View in: PubMed
    Score: 0.225
  81. Validation of the Corona-Score for rapid identification of SARS-CoV-2 infections in patients seeking emergency department care in the United States. Clin Chem Lab Med. 2020 08 10; 58(12):e311-e313.
    View in: PubMed
    Score: 0.224
  82. Letter to the Editor - Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report. Prog Cardiovasc Dis. 2020 Sep - Oct; 63(5):702-703.
    View in: PubMed
    Score: 0.223
  83. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)? Clin Chem Lab Med. 2020 08 27; 58(9):1415-1422.
    View in: PubMed
    Score: 0.222
  84. Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Chem Lab Med. 2020 06 25; 58(7):1135-1138.
    View in: PubMed
    Score: 0.222
  85. Analysis of clinical and demographic heterogeneity of patients dying from COVID-19 in Brazil versus China and Italy. Braz J Infect Dis. 2020 May - Jun; 24(3):273-275.
    View in: PubMed
    Score: 0.221
  86. Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19). Diagnosis (Berl). 2020 05 26; 7(2):85-90.
    View in: PubMed
    Score: 0.221
  87. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis (Berl). 2020 05 26; 7(2):91-96.
    View in: PubMed
    Score: 0.221
  88. COVID-19 and obesity: links and risks. Expert Rev Endocrinol Metab. 2020 07; 15(4):215-216.
    View in: PubMed
    Score: 0.221
  89. In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. Mayo Clin Proc. 2020 07; 95(7):1553-1556.
    View in: PubMed
    Score: 0.221
  90. Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide. Mayo Clin Proc. 2020 07; 95(7):1445-1453.
    View in: PubMed
    Score: 0.221
  91. The death rate for COVID-19 is positively associated with gross domestic products. Acta Biomed. 2020 05 11; 91(2):224-225.
    View in: PubMed
    Score: 0.220
  92. Is there evidence of intra-uterine vertical transmission potential of COVID-19 infection in samples tested by quantitative RT-PCR? Eur J Obstet Gynecol Reprod Biol. 2020 Jun; 249:100-101.
    View in: PubMed
    Score: 0.219
  93. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19). Eur J Prev Cardiol. 2020 06; 27(9):906-908.
    View in: PubMed
    Score: 0.219
  94. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019. Mayo Clin Proc. 2020 06; 95(6):1222-1230.
    View in: PubMed
    Score: 0.219
  95. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA Cardiol. 2021 12 01; 6(12):1451-1460.
    View in: PubMed
    Score: 0.061
  96. Laparoscopic surgery during the COVID-19 pandemic: detection of SARS-COV-2 in abdominal tissues, fluids, and surgical smoke. Langenbecks Arch Surg. 2021 Jun; 406(4):1007-1014.
    View in: PubMed
    Score: 0.058
  97. Diabetes mellitus association with coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. J Diabetes. 2020 Nov; 12(11):851-855.
    View in: PubMed
    Score: 0.057
  98. Acute Kidney Injury is Associated with Worse Prognosis In COVID-19 Patients: A Systematic Review and Meta-analysis. Acta Biomed. 2020 09 07; 91(3):e2020029.
    View in: PubMed
    Score: 0.056
  99. Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis. Curr Probl Cardiol. 2020 Aug; 45(8):100617.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.